Intramyocardial calcification in apical hypertrophic cardiomyopathy assessed using multimodality imaging: a case

Ilaria Radano1, Barbara Mabritto1, Stefania Luceri1

  • 1Department of Cardiology, Mauriziano Hospital, Torino, Italy.

ESC Heart Failure
|April 18, 2024
PubMed

Insights

Apical hypertrophic cardiomyopathy (ApHCM) can involve intramyocardial calcification, potentially mimicking endomyocardial fibrosis (EMF). Inflammatory triggers may contribute to fibrosis and calcification in ApHCM patients.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Pathology

Background:

  • Apical hypertrophic cardiomyopathy (ApHCM) is a variant of hypertrophic cardiomyopathy characterized by apical obliteration and diastolic dysfunction.
  • It frequently affects middle-aged males and can lead to microvascular ischemia.

Observation:

  • This study reports five cases of ApHCM with evidence of intramyocardial calcification on echocardiography.
  • Cardiac MRI revealed hypointensity on early gadolinium enhancement (EGE) sequences (suggesting calcium) and hyperintensity on late gadolinium enhancement (LGE) sequences (suggesting fibrosis).

Findings:

  • The imaging findings suggest a potential diagnosis of endomyocardial fibrosis (EMF), characterized by scarring and dystrophic calcification.
  • This series represents the largest description of ApHCM with these features to date.
  • Coexistent inflammatory triggers were identified in all patients, suggesting a role in the development of small vessel disease.

Implications:

  • The findings suggest a link between apical fibrosis/calcification and microvascular ischemia in ApHCM.
  • Inflammatory comorbidities may exacerbate microvascular stress in the context of cardiac hypertrophy.
  • This research highlights a potential pathway involving inflammation, hypertrophy, fibrosis, and calcification in ApHCM.